Top Markets
Coin of the day
InDex Pharmaceuticals Holding AB (publ) InDex Pharmaceuticals Holding AB (publ)

InDex Pharmaceuticals Holding AB (publ)

INDEX
Clasificación en acciones #28997
InDex Pharmaceuticals Holding AB (publ) is a pharmaceutical firm dedicated to... InDex Pharmaceuticals Holding AB (publ) is a pharmaceutical firm dedicated to developing therapeutic solutions for patients affected by ulcerative colitis. The company's flagship drug candidate, Cobitolimod, is presently in Phase III clinical trials, targeting the treatment of moderate to severe ulcerative colitis. Furthermore, InDex is progressing a pipeline of other DNA-based immunomodulatory sequences, which are in the preclinical phase, designed to address various immunological conditions. This enterprise was established in 2000 and operates from its headquarters in Solna, Sweden.
Precio por acción
$0.04406501
Última sincronización: 2024-07-09
Capitalización bursátil
$23.47M
Cambio (1 día)
-0.48%
Cambio (1 año)
0.00%
País
SE
Comercio InDex Pharmaceuticals Holding AB (publ) (INDEX)

Categoría

Historial del precio de la acción de InDex Pharmaceuticals Holding AB (publ) (INDEX)
Precio más alto de cierre: $0.04 el 2024-07-01

Precio más bajo de cierre: $0.27 el 2016-10-01
Historial del precio de la acción de InDex Pharmaceuticals Holding AB (publ) desde 2016 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2024 87.14%
2023 -26.23%
2022 -50.30%
2021 -15.30%
2020 -67.25%
2019 -14.75%
2018 30.01%
2017 -11.67%
2016 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$547.81 40.19%
US
$1.02K 55.56%
NL
$152.85 447.65%
US
$117.42 -19.34%
AU
$753.28 8.59%
CH